Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PGK1 | P00558 | 2/20 | 0.33 |
| ▸ | PGK2 | P07205 | 2/20 | 0.33 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.33 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | ACP3 | P15309 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17491576 | 0.77 | KDM4E (0.41) | KDM4ETSHRTDP1PGK1PGK2 | |
| SCHEMBL15641961 | 0.74 | KDM4E (0.36) | KDM4ETSHRTDP1 | |
| SCHEMBL15413307 | 0.71 | KDM4E (0.38) | KDM4ETSHRTDP1 | |
| SCHEMBL5572612 | 0.69 | KDM4E (0.37) | KDM4ETSHRTDP1 | |
| SCHEMBL21049195 | 0.69 | KDM4E (0.37) | KDM4ETSHRTDP1 | |
| SCHEMBL29241367 | 0.67 | KDM4E (0.39) | KDM4ETSHRTDP1PGK1PGK2 | |
| SCHEMBL776761 | 0.65 | KDM4E (0.33) | KDM4ETSHRTDP1 | |
| SCHEMBL28709498 | 0.65 | KDM4E (0.46) | KDM4ETSHRTDP1PGK1PGK2 | |
| SCHEMBL20261810 | 0.63 | KDM4E (0.40) | KDM4ETSHRTDP1PGK1PGK2 | |
| SCHEMBL2991838 | 0.63 | TDP1 (0.35) | KDM4ETSHRTDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10301537-B2 | Methods for recovering hydrocarbon materials from subterranean formations | ACULON INC. (US) | 2019-05-28 | — | — | US | disclosed |
| US-20180194993-A1 | Methods For Recovering Hydrocarbon Materials From Subterranean Formations | ACULON INC. | 2018-07-12 | — | — | US | disclosed |
| US-20170253793-A1 | Methods For Recovering Hydrocarbon Materials From Subterranean Formations | ACULON INC. | 2017-09-07 | — | — | US | disclosed |
| US-20150252656-A1 | Methods For Recovering Hydrocarbon Materials From Subterranean Formations | ACULON, INC. (US) | 2015-09-10 | — | — | US | disclosed |
| US-8337985-B2 | Coated substrates, organometallic films and methods for applying organometallic films to substrates | ACULON, INC. (US) | 2012-12-25 | — | — | US | disclosed |
| US-20110091729-A1 | Coated substrates, organometallic films and methods for applying organometallic films to substrates | ACULON, INC. (US) | 2011-04-21 | — | — | US | disclosed |
| US-7901777-B2 | Coated substrates, organometallic films and methods for applying organometallic films to substrates | ACULON, INC. (US) | 2011-03-08 | — | — | US | disclosed |
| US-20100209711-A1 | Coated substrates, organometallic films and methods for applying organometallic films to substrates | ACULON, INC. | 2010-08-19 | — | — | US | disclosed |
| US-7740940-B2 | Coated substrates, organometallic films and methods for applying organometallic films to substrates | ACULON, INC. (US) | 2010-06-22 | — | — | US | disclosed |
| EP-2094400-A2 | COATED SUBSTRATES, ORGANOMETALLIC FILMS AND METHODS FOR APPLYING ORGANOMETALLIC FILMS TO SUBSTRATES | Aculon, Inc. (US) | 2009-09-02 | — | — | EP | disclosed |
| US-20080152930-A1 | Coated substrates, organometallic films and methods for applying organometallic films to substrates | ACULON, INC. | 2008-06-26 | — | — | US | disclosed |
| WO-2008060582-A2 | COATED SUBSTRATES, ORGANOMETALLIC FILMS AND METHODS FOR APPLYING ORGANOMETALLIC FILMS TO SUBSTRATES | ACULON, INC. (US) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110091729-A1 | Coated substrates, organometallic films and methods for applying organometallic films to substrates | SOD1, AS3MT, SOD3 | KDM4E 2177/4885TSHR 4396/4885TDP1 2205/4885 |
| US-20100209711-A1 | Coated substrates, organometallic films and methods for applying organometallic films to substrates | SOD1, AS3MT, SOD3 | KDM4E 2177/4885TSHR 4396/4885TDP1 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.